SARS-CoV-2 in the Air: What’s Known and What Isn’t

Evidence suggests that COVID-19 is primarily an airborne disease. Yet the details of how transmission occurs are still debated and frequently misunderstood.

Written byAlejandra Manjarrez, PhD
| 9 min read
Woman waiting in line at the airport, carrying a bag and standing next to two other suitcases. She is wearing a N95 face mask.
Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

During the first months of the COVID-19 pandemic, many public health authorities promoted hand-washing and maintaining six feet of distance, with the idea that SARS-CoV-2 was spread primarily in relatively large respiratory droplets that soon fell from the air after being exhaled, potentially contaminating surfaces. But epidemiological and animal studies soon pointed to the importance of smaller, airborne droplets known as aerosols in transmission. By now, the evidence is overwhelming, and COVID-19 is acknowledged by most experts as an airborne disease.

The debate, though, does not seem to be settled. There are still a few scientists who, even while they acknowledge that airborne transmission is possible, claim that infection by large droplets or via surfaces could also be responsible for the bulk of cases. Additionally, in some cases health policy has been slow to catch up to the state of knowledge around the ability of aerosols to transmit SARS-CoV-2.

Scientists ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • alejandra manjarrez

    Alejandra Manjarrez is a freelance science journalist who contributes to The Scientist. She has a PhD in systems biology from ETH Zurich and a master’s in molecular biology from Utrecht University. After years studying bacteria in a lab, she now spends most of her days reading, writing, and hunting science stories, either while traveling or visiting random libraries around the world. Her work has also appeared in Hakai, The Atlantic, and Lab Times.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies